Product Overview
[Drug Name]
Generic Name: Thymosin Enteric-Coated Tablets
Trade Name: Kangnaier Thymosin Enteric-Coated Tablets 15mg*12 Tablets
Pinyin Code: KangNaiEr XiongXianZuoChangRongPian 15mg*12 Tablets
[Main Ingredient]
The main ingredient of this product is thymosin.
[Properties]
This product is an enteric-coated tablet. After removing the coating, it appears off-white or light yellow to yellow-brown.
[Indications/Main Functions]
1. For patients with chronic hepatitis B. 2. Various primary or secondary T-cell deficiency diseases (e.g., congenital immunodeficiency in children). 3. Certain autoimmune diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus, childhood bronchial asthma, and asthmatic bronchitis). 4. Various diseases characterized by impaired cellular immunity (e.g., viral hepatitis, prevention of upper respiratory tract infections, and stubborn oral ulcers). 5. Adjunctive treatment for tumors.
[Specifications]
15mg x 12 tablets (Cornell)
[Dosage and Administration]
Oral. 5-30mg per dose, 1-3 times daily or as directed by a physician.
[Adverse Reactions]
1. Well tolerated. Some may experience adverse reactions such as nausea, fever, dizziness, chest tightness, and weakness. A few patients may experience occasional drowsiness. 2. Patients with chronic hepatitis B may experience a transient increase in ALT levels when using this product. If there are no signs of liver failure, this product can be continued. 3. A very small number of patients may experience mild allergic reactions, which resolve upon discontinuation of the drug.
[Contraindications]
1. This product is contraindicated in patients with a history of allergic reactions or organ transplant recipients. 2. This product is contraindicated in patients with hyperthymic or thymic tumors.
[Drug Interactions]
1. This product has been used in combination with many commonly used medications, including interferons, anti-inflammatory drugs, antibiotics, hormones, analgesics, antihypertensive drugs, diuretics, cardiovascular medications, central nervous system medications, and contraceptives, without any interference. 2. This product, when used in combination with interferon, has a synergistic effect in improving immune function. 3. This product, when used in combination with antibiotics, can enhance antibacterial effects. 4. This product, when used in combination with chemotherapy drugs, can reduce the toxic side effects of chemotherapy.
[Precautions]
1. This product exerts its therapeutic effect by enhancing the patient's immune function. Therefore, it should not be used in patients undergoing immunosuppressive therapy (e.g., organ transplant recipients) unless the benefits clearly outweigh the risks. 2. Liver function should be checked regularly during treatment. 3. Use with caution in patients under 18 years of age.
[Pharmacology and Toxicology]
This product is an immunomodulatory drug. It regulates and enhances human cellular immune function, promoting the maturation of T lymphocytes. It can also promote the maturation of T lymphocytes in peripheral blood after mitogen activation. It increases the secretion of various lymphokines (e.g., interferons α and γ, interleukin-2, and interleukin-3) by T cells in response to various antigens or mitogens, and increases the levels of lymphokine receptors on T cells. It also enhances lymphocyte responses by activating T4 helper cells. Furthermore, it may affect the chemotaxis of NK precursor cells, which become more cytotoxic after exposure to interferon. Furthermore, it can enhance the body's ability to resist radiation. Therefore, it has the effect of regulating and enhancing the body's cellular immune function.
